A Study of Remternetug Versus Placebo in Early Alzheimer’s Disease Participants at Risk for Cognitive and Functional Decline
TITLE:
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo.
MEDICAL CONTION:
Alzheimer's Disease
AGE:
55 Years to 80 Years
SEX/GENDER:
Male & Female